Betting on Corps.
Prof. Talley said the final's fact patterns will come from the Wall Street Journal. Well, I've been doing my reading and have my first prime candidate for a fact pattern that we may see on the final:
Desperate for a Cure
In particular, the craziness of forming the company, floating the money to keep the company going, and forming the partnership with the other manufacturer are fantastic facts for creating a sprawling issue spotter. Between the business man and the scientist, we could get a number of great agency questions. What if one promises free medicine to the kids who come in to talk? And how do all the private donations affect the company when it goes public? Are those prior claims? What share of the company do they own? Any? As the semester goes by, I imagine this article could only spawn a thousand more hypotheticals.
Note how well this fits to with Talley's hint that he may ask about ratification, and that funny first element of existence. Ratification by Novazyme cannot occur until it formally exists, even if the scientist and business man are running around making promises. This fact pattern would make it really easy to slip this question in.
So, there you go. You heard it hear first. The story of Novazyme Phamaceuticals will be appearing on the Corporations final. Current odds, 3:1.
Desperate for a Cure
In particular, the craziness of forming the company, floating the money to keep the company going, and forming the partnership with the other manufacturer are fantastic facts for creating a sprawling issue spotter. Between the business man and the scientist, we could get a number of great agency questions. What if one promises free medicine to the kids who come in to talk? And how do all the private donations affect the company when it goes public? Are those prior claims? What share of the company do they own? Any? As the semester goes by, I imagine this article could only spawn a thousand more hypotheticals.
Note how well this fits to with Talley's hint that he may ask about ratification, and that funny first element of existence. Ratification by Novazyme cannot occur until it formally exists, even if the scientist and business man are running around making promises. This fact pattern would make it really easy to slip this question in.
So, there you go. You heard it hear first. The story of Novazyme Phamaceuticals will be appearing on the Corporations final. Current odds, 3:1.
Labels: Classes/Professors
posted by Tom Fletcher at 12:02 PM
4 Comments:
Not only does TF pay attention in the class (one of the few on the row in which he sits) but he's actively looking for future exam questions on the WSJ pages?!?!
TF - you are a gentleman and a scholar.
More likely that Talley will use a bunch of questions from his 4 unit USC class, which covered material that was not covered in the 3 unit class at Boalt. At least that is what he did last semester. Worst exam ever!
What was wrong with Talley's corps final from last semester?
Bet #2: today's articles on H-P's board of directors, secrecy and power struggles.
Post a Comment
<< Home